IHE vs. BBP
Compare and contrast key facts about iShares U.S. Pharmaceuticals ETF (IHE) and Virtus LifeSci Biotech Products ETF (BBP).
IHE and BBP are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. IHE is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Select Pharmaceuticals Index. It was launched on May 5, 2006. BBP is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Products Index. It was launched on Dec 17, 2014. Both IHE and BBP are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IHE or BBP.
Key characteristics
| IHE | BBP | |
|---|---|---|
| YTD Return | 7.35% | -3.38% |
| 1Y Return | 17.18% | 5.23% |
| 3Y Return (Ann) | 7.49% | 2.53% |
| 5Y Return (Ann) | 11.16% | 7.13% |
| Sharpe Ratio | 1.26 | 0.20 |
| Daily Std Dev | 13.51% | 22.24% |
| Max Drawdown | -35.30% | -44.32% |
| Current Drawdown | -4.61% | -11.09% |
Correlation
The correlation between IHE and BBP is 0.71, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
IHE vs. BBP - Performance Comparison
In the year-to-date period, IHE achieves a 7.35% return, which is significantly higher than BBP's -3.38% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
IHE vs. BBP - Expense Ratio Comparison
IHE has a 0.42% expense ratio, which is lower than BBP's 0.79% expense ratio.
Risk-Adjusted Performance
IHE vs. BBP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and Virtus LifeSci Biotech Products ETF (BBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IHE vs. BBP - Dividend Comparison
IHE's dividend yield for the trailing twelve months is around 3.29%, while BBP has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 3.29% | 4.16% | 6.02% | 4.48% | 3.57% | 4.19% | 3.76% | 4.08% | 2.75% | 5.78% | 3.60% | 3.19% |
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% | 0.00% | 0.00% |
Drawdowns
IHE vs. BBP - Drawdown Comparison
The maximum IHE drawdown since its inception was -35.30%, smaller than the maximum BBP drawdown of -44.32%. Use the drawdown chart below to compare losses from any high point for IHE and BBP. For additional features, visit the drawdowns tool.
Volatility
IHE vs. BBP - Volatility Comparison
The current volatility for iShares U.S. Pharmaceuticals ETF (IHE) is 3.32%, while Virtus LifeSci Biotech Products ETF (BBP) has a volatility of 5.14%. This indicates that IHE experiences smaller price fluctuations and is considered to be less risky than BBP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.